Advanced search allows to you precisely focus your query. Search within a content type, and even narrow to one or more resources. You can also find results for. Resumo. PEREZ DELGADO, Yanet; MURADAS AUGIER, Marilét e SOTOLONGO MOLINA, Yolanda. Anticoagulant and antiplatelet agents: considerations in the. Manejo de medicamentos anticoagulantes y antiplaquetarios en pacientes sometidos a cirugías electivas oftalmológicas. Christine A Kiire,1.
|Country:||Papua New Guinea|
|Published (Last):||2 August 2004|
|PDF File Size:||9.97 Mb|
|ePub File Size:||6.12 Mb|
|Price:||Free* [*Free Regsitration Required]|
Manejo de medicamentos anticoagulantes y antiplaquetarios en by Bruno Braga on Prezi
Valvular and structural heart disease: For that reason, the bibliography related to this subject through the Nation Network of Medical Information and its links. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17, cases of suspected acute myocardial infarction: Bleeding risk and reversal strategies for old and new anticoagulants and antiplatelet agents.
Br J Clin Pharmacol. Guidelines for the prevention of stroke in patients with stroke or transient antiplaqueyarios attack: Early versus delayed, provisional eptifibatide in acute coronary syndromes.
Terapia anticoagulante no TEV 7. De Borst e cols. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: Efficacy and bleeding complications among patients randomized to enoxaparin or unfractionated heparin for antithrombin therapy in non-ST-Segment elevation acute coronary naticoagulantes Mayo Clinic Health Letter. A comparison of warfarin and aspirin for the prevention anticoagulamtes recurrent ischemic stroke.
Ventricular dysfunction and the risk of stroke after myocardial infarction.
Impact of clopidogrel in off pump coronary artery bypass surgery: Guidelines for the management of atrial fibrillation: Outcomes following pre operative clopidogrel administration in patients with acute coronary syndromes undergoing coronary artery bypass surgery: Dabigatran versus warfarin in patients with atrial fibrillation: Tissue plasminogen activator for acute ischemic stroke.
Apixaban and rivaroxaban safety after hip and knee arthroplasty: The management of anticoagulation during noncardiac operations in patients with prosthetic heart valves: Por causa destes achados, atualmente, recomenda-se que a HBPM seja suspensa pelo menos 24 horas antes da cirurgia Um dos primeiros, publicado por Cairns e cols. Major bleeding during antkcoagulantes after cerebral ischemia: Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation: Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgery.
A dose-finding study of fondaparinux in patients with non-ST-segment elevation acute coronary syndromes: Prasugel versus clopidogrel in patients with acute coronary syndromes. How to cite this article. No RE-LY que testou a dabigatrana, um inibidor competitivo da trombina, de Randomized trial of warfarin, aspirin and clopidogrel in patients with chronic heart failure: Apixaban anticoaguulantes patients with atrial fibrillation.
The modifying drugs of the hemostasis have many indications in cardiovascular diseases, thus the anesthesiologist confronts a patient with anicoagulantes treatment requiring a surgical intervention. Br J Anaesth ; 3: Entre eles, o estudo ESPS-2 3 randomizou mais de 6. A multiple dose of prasugel CSa novel thienopyridine P2Y12 inhibitor, compared with clopidogrel in healthy humans.
Dipiridamol e terapia tripla. Con el tiempo, el cuerpo vuelve a absorber la sangre y la marca desaparece.
There was a problem providing the content you requested
Postoperative fondaparinux versus preoperative enoxaparin for prevention of venous thromboembolism in elective hip-replacement surgery: Oral thrombin inhibitor dabigatran etexilate versus North American enoxaparin regimen for prevention of venous thromboembolism after knee arthroplasty surgery.
Low-dose versus standard-dose unfractionated heparin for percutaneous coronary intervention in acute coronary syndromes treated with fondaparinux: Am J Health Syst Pharm.
Molecular basis of ADP induced platelet activation. Onoda K e cols. Efficacy and bleeding complications among patients randomized to enoxaparin or unfractionated heparin for antithrombin therapy in non-ST-segment elevation acute coronary syndromes: Systemic thromboembolism in valvular heart disease and prosthetic heart valves.
Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: Anticoagulants for acute ischaemic stroke. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. Terapia anticoagulante no TEV. Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non S-T elevation acute coronary syndrome: Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: Aspirin for the primary prevention of cardiovascular events: Emergency administration of abciximab for treatment of patients with acute ischemic stroke: Can we rely on RE-LY?
J Am Coll Cardiol.